13 insiders reported 15 Form 4 transactions for Traws Pharma, Inc. (TRAW) over the past 18 months (most recent 2026-04-28). Recent activity: ORBIMED ADVISORS LLC (Insider) Buy 597,729 shares, OrbiMed Capital GP VIII LLC (Insider) Buy 597,729 shares, Parker Charles Nolan (Chief Financial Officer) Buy 15,393 shares, Dukes Iain D. (Chief Executive Officer) Buy 36,943 shares, Shoemaker Mary Teresa (Director) Buy 6,157 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | ORBIMED ADVISORS LLC | Insider | Buy | 597,729 | $998,207 |
| 2026-04-28 | OrbiMed Capital GP VIII LLC | Insider | Buy | 597,729 | $998,207 |
| 2026-04-08 | Parker Charles Nolan | Chief Financial Officer | Buy | 15,393 | $0 |
| 2025-12-16 | Dukes Iain D. | Chief Executive Officer | Buy | 36,943 | $0 |
| 2025-12-16 | Shoemaker Mary Teresa | Director | Buy | 6,157 | $0 |
| 2025-12-16 | CAUTREELS WERNER | Director | Buy | 4,874 | $0 |
| 2025-12-16 | Clarke Trafford | Director | Buy | 6,157 | $0 |
| 2025-12-16 | Redfield Robert | Chief Medical Officer | Buy | 16,419 | $0 |
| 2025-12-16 | Pauza Charles David | Chief Science Officer Virology | Buy | 18,471 | $0 |
| 2025-12-16 | STOVER JACK E | Director | Buy | 6,157 | $0 |
| 2025-12-16 | Leaman John Harold | Director | Buy | 4,058 | $0 |
| 2025-12-16 | Savchuk Nikolay | Chief Operating Officer | Buy | 16,419 | $0 |
| 2025-04-08 | TPAV, LLC | Insider | Sell | 605,531 | $0 |
| 2025-04-08 | Savchuk Nikolay | Chief Operating Officer | Sell | 605,531 | $0 |
| 2025-02-19 | CAUTREELS WERNER | Chief Executive Officer | Buy | 96,348 | $963 |
Source: SEC Form 4 filings · as of 2026-04-28
